Leads concentrated equity strategies that combine bottom-up fundamental research with event-driven trading across technology and healthcare names, serving institutional and high-net-worth clients.
Mark Albers brings experience in portfolio construction, risk management, and public market deal sourcing, with a track record of scaling positions into thematic secular trends and executing liquidity-aware exits.
Investment approach emphasizes high-conviction bets, disciplined position sizing, and active engagement with company management to drive value.
Leads concentrated equity strategies that combine bottom-up fundamental research with event-driven trading across technology and healthcare names, serving institutional and high-net-worth clients.
Mark Albers brings experience in portfolio construction, risk management, and public market deal sourcing, with a track record of scaling positions into thematic secular trends and executing liquidity-aware exits.
Investment approach emphasizes high-conviction bets, disciplined position sizing, and active engagement with company management to drive value.
Combines concentrated, bottom-up fundamental research with event-driven trading to capture asymmetric returns in technology and healthcare. Focuses on high-conviction, conviction-weighted positions sized to liquidity and risk budgets, blending thematic secular exposures with tactical, liquidity-aware entry and exit execution. Emphasizes active engagement with management, rigorous downside protection through stop frameworks and scenario analysis, and scalable portfolio construction that balances conviction alpha with institutional risk controls over a multi-quarter to multi-year horizon.
Combines concentrated, bottom-up fundamental research with event-driven trading to capture asymmetric returns in technology and healthcare. Focuses on high-conviction, conviction-weighted positions sized to liquidity and risk budgets, blending thematic secular exposures with tactical, liquidity-aware entry and exit execution. Emphasizes active engagement with management, rigorous downside protection through stop frameworks and scenario analysis, and scalable portfolio construction that balances conviction alpha with institutional risk controls over a multi-quarter to multi-year horizon.
| Trades 259 | Longs Won 193/259 74% | Profit Factor 58.86 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $245,088.22 |
| Average Win $97,224.88 | Best Trade (Jul 14) $2.68M | Sharpe Ratio -10.68 |
| Average Loss -$4,829.95 | Worst Trade (Jul 10) -$89,842.48 | Z-Score 7.57 (100%) |
| Commissions $0 | Avg. Trade Length 11m | Expectancy $71,218.63 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 23,810 | 21,429 | 19,048 | 16,667 | 14,286 | 11,905 | 9,524 | 7,143 | 4,762 | 2,381 |